| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.55B | 38.11B | 36.34B | 34.19B | 29.06B | 24.98B |
| Gross Profit | 8.22B | 8.13B | 8.24B | 7.85B | 6.61B | 6.09B |
| EBITDA | 5.28B | 5.31B | 5.14B | 5.05B | 4.22B | 4.10B |
| Net Income | 3.23B | 3.28B | 3.16B | 3.13B | 2.69B | 2.52B |
Balance Sheet | ||||||
| Total Assets | 25.06B | 27.05B | 25.71B | 23.50B | 21.74B | 18.99B |
| Cash, Cash Equivalents and Short-Term Investments | 11.19B | 10.83B | 12.88B | 12.12B | 10.20B | 11.27B |
| Total Debt | 200.00M | 200.00M | 200.00M | 200.00M | 700.00M | 200.00M |
| Total Liabilities | 6.40B | 6.86B | 7.24B | 6.69B | 6.64B | 5.17B |
| Stockholders Equity | 18.66B | 20.19B | 18.47B | 16.80B | 15.10B | 13.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.39B | 2.98B | 3.18B | 1.83B | 4.39B |
| Operating Cash Flow | 0.00 | 3.41B | 3.19B | 3.42B | 1.95B | 4.42B |
| Investing Cash Flow | 0.00 | -3.89B | -923.00M | 449.00M | -1.71B | 31.00M |
| Financing Cash Flow | 0.00 | -1.57B | -1.51B | -1.95B | -1.30B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.78B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
74 Outperform | ¥74.99B | 13.80 | 17.96% | 1.83% | 10.56% | 27.45% | |
70 Outperform | ¥43.10B | 14.05 | 17.50% | 2.88% | 4.87% | 3.91% | |
69 Neutral | ¥31.97B | 8.54 | ― | 2.22% | 12.35% | 56.74% | |
65 Neutral | ¥30.39B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |